Suraksha Diagnostic Limited has announced the scheduling of a virtual earnings conference call for analysts, institutional investors, and organisations to discuss its financial results for Q4 and FY 2025-26. The call is set for Friday, 22 May 2026, at 12:00 PM IST, and will be conducted through virtual/digital means. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call Details

The conference call will focus on the company's audited financial performance for the quarter and financial year ended 31 March 2026. The investor presentation will be presented and discussed during the meeting and will subsequently be made available on the company's official website at www.surakshanet.com . The company has clarified that no unpublished price-sensitive information will be shared during the call, and all discussions will be based on publicly available information.

Key details of the scheduled earnings call are as follows:

Company Participants

The following senior executives are scheduled to participate in the earnings call:

• Dr. Somnath Chatterjee — Chairman & Joint Managing Director
• Ms. Ritu Mittal — Joint Managing Director & Chief Executive Officer
• Mr. Bablu Shaw — General Manager - Finance
• Mr. Niren Kaul — Chief Sales Officer
• Mr. Balgopal Jhunjhunwala — Regional Business Head

Conference Dial-In Information

Participants can join the call using the following dial-in numbers:

Participants are encouraged to pre-register via the Diamond Pass link to avoid wait time at the time of joining the call.

Regulatory Disclosure

The intimation was filed in compliance with BSE Circular No.: 20230714-34 dated 14 July 2023 and NSE Circular No.: NSE/CML/2023/57 dated 14 July 2023. The company has noted that the schedule of the earnings call is subject to change due to exigencies on the part of the company, analysts, institutional investors, or organisations. The disclosure was signed by Mamta Jain, Company Secretary & Compliance Officer of Suraksha Diagnostic Limited.

Suraksha Diagnostic Limited has scheduled a meeting of its Board of Directors for Thursday, May 21, 2026. The meeting will be held at the company's registered office to discuss and approve the audited financial results for the quarter and financial year ended March 31, 2026.

Agenda for the Meeting

The primary agenda for the board meeting includes the consideration and approval of the audited standalone and consolidated financial results for the fourth quarter and the full financial year ending March 31, 2026. Additionally, the board will deliberate on the recommendation of a dividend, if any, on equity shares for the financial year ended March 31, 2026.

Trading Window Closure

In accordance with the company's Internal Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the company was closed on April 1, 2026. This closure affected all directors, Key Managerial Personnel (KMPs), designated persons, employees, connected persons, and their immediate relatives.

The trading window is scheduled to reopen after the expiry of 48 hours from the date of declaration of the financial results. This measure is in line with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Details

The intimation regarding the board meeting was submitted to BSE Limited and The National Stock Exchange of India Limited on May 13, 2026. The company has also made this information available on its official website.